Dimension Vista Loci Ca 125 Flex Reagent Cartridge,And Dimensions Vista Loci 6 Cal, Model#'s K6455, and KC604
Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125). 510(k) K100321, from Siemens Healthcare Diagnostics (Newark, DE). Product code LTK, class 2.
As of Nov 20, 2026, K100321 is an FDA 510(k) held by Siemens Healthcare Diagnostics, substantially equivalent on Apr 12, 2011 after 432 days, with no recalls tied to it in FDA's recall database.
- Review time: 432 days
- Recalls: 0
- Cited as a predicate by: 1 device
The LOCI CA 125 II™ method is an in vitro diagnostic test for the quantitative measurement of CA 125 antigen in human serum and lithium heparin and EDTA plasma on the Dimension Vista® System. Measurements of CA 125 are used as an aid in monitoring disease progress or response to therapy or for the recurrent or residual disease for patients with epithelial ovarian cancer.
- Ca 125 Assay for The Advia Centaur SystemK020828 · Bayer Corp. · Jul 24, 2002
- Dimension Vista (R) Afp Flex(R) Reagent Cartridge, Model K6454, Dimension Vista (R) Loci 5 Calibrator, Model KC600K071597 · Dade Behring, Inc. · Jun 4, 2008
- Dimension Vista Carcinoembryonic Antigen Flex Reagent Cartridge (Cea)K071603 · Dade Behring, Inc. · Jun 25, 2008
- GE EchopacK120221 · GE Healthcare · Mar 30, 2012
- Access OV MonitorK240479 · Beckman Coulter, Inc. · May 10, 2024
- Immulite/Immulite 1000 Om-Ma, Immulite 2000 Om-MaK213510 · Siemens Healthcare Diagnostics Products, Ltd. · Sep 8, 2023
- VITROS Immuodiagnostic Products CA 125 II Reagent PackK221355 · Ortho Clinical Diagnostics · Dec 12, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 4, 2010
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files